Promoted Content
Promoted Content

Find Clinical Drug Pipeline Developments & Deals by Lipidio Pharmaceuticals

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
Therapeutic Area filter
    Study Phase filter
      Country filter
        News Type filter
          Company filter
            refresh

            Companies By Therapeutic Area Full Screen

            Development Status Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): GDD3898

            Therapeutic Area: Nutrition and Weight Loss Product Name: Undisclosed

            Highest Development Status: Phase II Product Type: Undisclosed

            Partner/Sponsor/Collaborator: Maxim Merchant Capital

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Series A Financing March 03, 2020

            Details:

            The financing will support the development of its lead therapeutic candidate GDD3898.